Stay updated on Tralokinumab Combo in Japanese AD: Clinical Trial

Sign up to get notified when there's something new on the Tralokinumab Combo in Japanese AD: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tralokinumab Combo in Japanese AD: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:49:56.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the efficacy evaluation of tralokinumab in combination with topical corticosteroids for treating moderate-to-severe atopic dermatitis in Japanese subjects.
    Difference
    0.1%
    Check dated 2024-06-06T14:33:59.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying that researchers are looking for Japanese subjects aged 18 years and above with a diagnosis of atopic dermatitis (AD) as defined by the Hanifin and Rajka criteria. Previously, no information was provided in this section.
    Difference
    21%
    Check dated 2024-05-22T21:38:34.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:29:47.000Z thumbnail image

Stay in the know with updates to Tralokinumab Combo in Japanese AD: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tralokinumab Combo in Japanese AD: Clinical Trial page.